www.360dx.com
Open in
urlscan Pro
104.18.29.67
Public Scan
Submitted URL: http://www.360dx.com/
Effective URL: https://www.360dx.com/
Submission: On September 16 via api from DE — Scanned from DE
Effective URL: https://www.360dx.com/
Submission: On September 16 via api from DE — Scanned from DE
Form analysis
2 forms found in the DOMGET /elastic-search
<form action="/elastic-search" method="get" id="views-exposed-form-search-autocomplete-page" accept-charset="UTF-8">
<div class="js-form-item form-item form-element__textfield">
<input class="elastic-autocomplete-input form-autocomplete form-text form-item__textfield ui-autocomplete-input" placeholder="Enter your keywords" data-drupal-selector="edit-search-phrase"
data-autocomplete-path="/admin/view_content/search_autocomplete" type="text" id="edit-search-phrase" name="search_phrase" value="" size="30" maxlength="128" data-once="autocomplete" autocomplete="off">
</div>
<div class="js-form-item form-item form-element__submit">
<button class="button button--icon js-form-submit form-submit" aria-label="button" title="Search">
<svg class="icon">
<use xlink:href="/profiles/custom/crain_core/themes/custom/gweb/dist/icons.svg#magnifying-glass"></use>
</svg>
</button>
</div>
<div data-drupal-selector="edit-actions" class="form-actions js-form-wrapper form-wrapper" id="edit-actions"></div>
</form>
GET /elastic-search
<form action="/elastic-search" method="get" id="views-exposed-form-search-autocomplete-page" accept-charset="UTF-8">
<div class="js-form-item form-item form-element__textfield">
<input class="elastic-autocomplete-input form-autocomplete form-text form-item__textfield ui-autocomplete-input" placeholder="Enter your keywords" data-drupal-selector="edit-search-phrase"
data-autocomplete-path="/admin/view_content/search_autocomplete" type="text" id="edit-search-phrase" name="search_phrase" value="" size="30" maxlength="128" data-once="autocomplete" autocomplete="off">
</div>
<div class="js-form-item form-item form-element__submit">
<button class="button button--icon js-form-submit form-submit" aria-label="button" title="Search">
<svg class="icon">
<use xlink:href="/profiles/custom/crain_core/themes/custom/gweb/dist/icons.svg#magnifying-glass"></use>
</svg>
</button>
</div>
<div data-drupal-selector="edit-actions" class="form-actions js-form-wrapper form-wrapper" id="edit-actions"></div>
</form>
Text Content
Skip to main content SISTER PUBLICATION LINKS * GenomeWeb * 360Dx * Precision Medicine Online * PMLS Events * RSS Feeds * Visit 360Dx on Twitter * Visit 360Dx on LinkedIn Premium Trial: Request an Annual Quote USER ACCOUNT MENU * My 360Dx * Profile * Newsletters * My Topics * Reading List * Log out Log in Subscribe Menu Close Menu MAIN NAVIGATION * My 360Dx * Profile * Newsletters * My Topics * Reading List * Log out * Business & Policy * Business News * Research Funding * Policy & Legislation * Regulatory News * Reimbursement * Clinical Lab Management * Diagnostics * Molecular Diagnostics * Immunoassays * Tissue-Based Testing * Clinical Chemistry * Hematology/Coagulation * Point-of-Care Testing * Companion Diagnostics * Disease Areas * Cancer * Infectious Disease * Cardiovascular Disease * Neurological & Psychological Disease * Autoimmune Disease * Inherited Disease * Reproductive Health * Respiratory * Gastrointestinal * COVID-19 * Resources * Webinars * White Papers * Job Listings * New Products * People in the News * FDA 510(k) Tracker: IVD Tests and Instruments * Coronavirus Test Tracker * Partner Content Premium Trial: Request an Annual Quote Log in Subscribe LACK OF STANDARDIZATION ACROSS MDX INFECTIOUS DISEASE TESTS COULD UNDERMINE PANDEMIC PREPAREDNESS PREMIUM Poor cross-compatibility may make it difficult to substitute components of automated sample processing and testing workflows in the case of shortages. QUEST DIAGNOSTICS CONSUMER-INITIATED ALZHEIMER'S BLOOD TEST RAISING CONCERNS AMONG EXPERTS PREMIUM Researchers and clinicians have highlighted the lack of data supporting the test and warned that false positive results could further tax overburdened memory clinics. NY STATE DATABASE OFFERS GLIMPSE INTO LABORATORY-DEVELOPED TESTING LANDSCAPE PREMIUM Large national labs and applications like oncology, genetics, and infectious disease dominate the database, which comprises more than 10,000 LDTs. RESEARCHERS USE DNA NANOBALLS, BIOSENSORS TO CREATE LOW-COST DIAGNOSTICS PREMIUM The creation of DNA nanoballs allows for the use of more simplified detection techniques, which potentially reduces the cost of testing. SCIPHER MEDICINE TO EXPAND ARTHRITIS THERAPY RESPONSE TEST, AIMING TO MAXIMIZE MEDICARE COVERAGE PREMIUM The company is collecting the data necessary to add at least two other drugs to its current TNFi response predictor, which it believes will accelerate adoption. DELVE BIO SEEKS TO COMMERCIALIZE UCSF METAGENOMIC PATHOGEN TEST PREMIUM In addition to proving clinical utility, the startup will have to navigate issues of regulatory strategy, sequencing technology, and additional indications. Business, Policy & Funding * MEDTECH EUROPE CALLS FOR REFORMS TO IVDR, MDR REGULATIONS * IN BRIEF THIS WEEK: QUEST DIAGNOSTICS, DANAHER, TRINITY BIOTECH, ONCGNOSTICS, PRENETICS * SCIPHER MEDICINE TO EXPAND ARTHRITIS THERAPY RESPONSE TEST, AIMING TO MAXIMIZE MEDICARE COVERAGE PREMIUM * DELVE BIO SEEKS TO COMMERCIALIZE UCSF METAGENOMIC PATHOGEN TEST PREMIUM * QLUCORE MOVES CLOSER TO IVDR CERTIFICATION OF DX SOFTWARE FOR LEUKEMIA TESTING PREMIUM Diagnostics * MEDTECH EUROPE CALLS FOR REFORMS TO IVDR, MDR REGULATIONS * SCIPHER MEDICINE TO EXPAND ARTHRITIS THERAPY RESPONSE TEST, AIMING TO MAXIMIZE MEDICARE COVERAGE PREMIUM * I-SPY 2 TRIAL TO EVALUATE NATERA'S SIGNATERA FOR POST-NEOADJUVANT BREAST CANCER MONITORING * RESEARCHERS USE DNA NANOBALLS, BIOSENSORS TO CREATE LOW-COST DIAGNOSTICS PREMIUM * MAINZ BIOMED STOCK SPIKES ON POSITIVE DATA FOR MRNA-ENHANCED COLORECTAL CANCER SCREENING ASSAY Disease Areas * SCIPHER MEDICINE TO EXPAND ARTHRITIS THERAPY RESPONSE TEST, AIMING TO MAXIMIZE MEDICARE COVERAGE PREMIUM * I-SPY 2 TRIAL TO EVALUATE NATERA'S SIGNATERA FOR POST-NEOADJUVANT BREAST CANCER MONITORING * MAINZ BIOMED STOCK SPIKES ON POSITIVE DATA FOR MRNA-ENHANCED COLORECTAL CANCER SCREENING ASSAY * QLUCORE MOVES CLOSER TO IVDR CERTIFICATION OF DX SOFTWARE FOR LEUKEMIA TESTING PREMIUM * A3P BIOMEDICAL, BIOAGILYTIX PARTNER TO BRING PROSTATE CANCER TEST TO US Clinical Lab Management * LOUISIANA LAB OWNER SENTENCED TO THREE YEARS IN FEDERAL PRISON FOR $45M LAB FRAUD SCHEME * LACK OF STANDARDIZATION ACROSS MDX INFECTIOUS DISEASE TESTS COULD UNDERMINE PANDEMIC PREPAREDNESS PREMIUM * QUEST DIAGNOSTICS CONSUMER-INITIATED ALZHEIMER'S BLOOD TEST RAISING CONCERNS AMONG EXPERTS PREMIUM * NY STATE DATABASE OFFERS GLIMPSE INTO LABORATORY-DEVELOPED TESTING LANDSCAPE PREMIUM * CHICAGO DOCTOR CONVICTED IN $9.5M GENETIC TESTING FRAUD CASE Breaking News * LOUISIANA LAB OWNER SENTENCED TO THREE YEARS IN FEDERAL PRISON FOR $45M LAB FRAUD SCHEME * MEDTECH EUROPE CALLS FOR REFORMS TO IVDR, MDR REGULATIONS * IN BRIEF THIS WEEK: QUEST DIAGNOSTICS, DANAHER, TRINITY BIOTECH, ONCGNOSTICS, PRENETICS * I-SPY 2 TRIAL TO EVALUATE NATERA'S SIGNATERA FOR POST-NEOADJUVANT BREAST CANCER MONITORING * MAINZ BIOMED STOCK SPIKES ON POSITIVE DATA FOR MRNA-ENHANCED COLORECTAL CANCER SCREENING ASSAY * A3P BIOMEDICAL, BIOAGILYTIX PARTNER TO BRING PROSTATE CANCER TEST TO US What's Popular? 1. MEDTECH EUROPE CALLS FOR REFORMS TO IVDR, MDR REGULATIONS 2. IN BRIEF THIS WEEK: QUEST DIAGNOSTICS, DANAHER, TRINITY BIOTECH, ONCGNOSTICS, PRENETICS 3. RESEARCHERS USE DNA NANOBALLS, BIOSENSORS TO CREATE LOW-COST DIAGNOSTICS PREMIUM 4. LACK OF STANDARDIZATION ACROSS MDX INFECTIOUS DISEASE TESTS COULD UNDERMINE PANDEMIC PREPAREDNESS PREMIUM 5. QUEST DIAGNOSTICS CONSUMER-INITIATED ALZHEIMER'S BLOOD TEST RAISING CONCERNS AMONG EXPERTS PREMIUM SPONSORSHIPS FOOTER * About us * Advertise * Contact * FAQ * Jobs * Sitemap * Submit A Tip Subscribe Privacy Policy. Terms & Conditions. Copyright © 2023 GenomeWeb, a business unit of Crain Communications. All Rights Reserved. Our site uses cookies and related technologies, as described in our Datenschutzerklärung, for purposes that may include site operation, analytics, enhanced user experience, or advertising. You may choose to consent to our use of these technologies or manage your own preferences. Akzeptieren Ablehnen Einstellungen verwalten